| [1] | Zhou Y., Liu J., Zhao Z., et al. (2025). The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050. Mil. Med. Res. 12:28. DOI:10.1186/s40779-025-00615-1 |
| [2] | Chen F., Yu L., Xie C., et al. (2024). Cardiovascular disease risk in early-onset vs late-onset type 2 diabetes in China: A population-based cross-sectional study. J. Diabetes 16:e13493. DOI:10.1111/1753-0407.13493 |
| [3] | Huo X., Gao L., Guo L., et al. (2016) Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 4:115-24. DOI:10.1016/S2213-8587(15)00508-2 |
| [4] | Ke D., Hong Y., Jiang X., et al. (2022) Clinical features and vitreous biomarkers of early-onset type 2 diabetes mellitus complicated with proliferative diabetic retinopathy. Diabetes Metab. Syndr. Obes. 15:1293-303. DOI:10.2147/DMSO.S362074 |
| [5] | Vounzoulaki E., Khunti K., Abner S.C., et al. (2020) Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis. BMJ 369:m1361. DOI:10.1136/bmj.m1361 |
| Chen X., Ke D., Sun J., et al. (2026). Vascular complications in early-onset type 2 diabetes in China: An emerging challenge. The Innovation Medicine 4:100248. https://doi.org/10.59717/j.xinn-med.2026.100248 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.